Skip to content

Study for epidemiologic survey and TCM syndrome distribution of interstitial lung disease

Study for epidemiologic survey and TCM syndrome distribution of interstitial lung disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075656
Enrollment
Unknown
Registered
2023-09-12
Start date
2023-09-12
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Interventions

Interstitial Lung Disease:Nil

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: ?Any gender, age = 18; ?Meet the diagnostic criteria for interstitial lung disease, including acute exacerbation and stable phase, in accordance with the 2002 American Thoracic Society (ATS) and European Respiratory Society (ERS) Expert Group Consensus, the 2018 Chinese Expert Consensus on the Diagnosis and Treatment of Connective Tissue Disease-Related Interstitial Lung Disease, and the 2019 Chinese Expert Consensus on the Diagnosis and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis; ?Patients volunteered to participate in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: ?Persons suffering from severe cardiovascular, hematologic, hepatic, renal and other organ dysfunctions; ?Persons with mental illnesses who are unable to cooperate with the research study; ?Persons with acute and chronic infectious diseases.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine syndromes;clinical characteristics;Lung function;Chest CT;

Secondary

MeasureTime frame
The Dampness Syndrome Scale of Chinese Medicine;St. George's respiratory questionnaire;Health Survey Summary Form (SF-36);Functional Status Assessment (HAQ);Improved UK Improved UK MRC Dyspnea Scale (mMRC);Borg rating scale;VAS visual simulation score;Generalized Anxiety Scale (GAD-7);Self-rating Tool Scale for Depression (PHQ-9);Self-immunity rheumatism index;Prognostic index of fibrosis;Tumor index;Kinase index;Inflammatory index;Blood gas analysis;electromyogram;

Countries

China

Contacts

Public ContactLin Lin

Guangdong Provincial Hospital of Chinese Medicine

drlinlin620@163.com+86 139 0300 2015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026